Ticker > Company >

Cian Healthcare share price

Cian Healthcare Ltd.

BSE: 542678 SECTOR: Pharmaceuticals & Drugs  19.95 K   19   2

3.60
0 0
BSE: 05 Sep 04:01 PM

Price Summary

Today's High

₹ 3.6

Today's Low

₹ 3.6

52 Week High

₹ 6.61

52 Week Low

₹ 2.97

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

9 Cr.

Enterprise Value

49.28 Cr.

No. of Shares

2.5 Cr.

P/E

0

P/B

0.21

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  16.86

CASH

0.73 Cr.

DEBT

41.01 Cr.

Promoter Holding

27.1 %

EPS (TTM)

₹  -7.86

Sales Growth

-13.04%

ROE

0.82 %

ROCE

5.54%

Profit Growth

-63.82 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Cian Healthcare Ltd.

celesta norwich jmsims gelios cardiac care trans I vac cianstar cinex blue care

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-13.04%
3 Year-6.72%
5 Year-1.21%

Profit Growth

1 Year-63.82%
3 Year6.04%
5 Year-9.87%

ROE%

1 Year0.82%
3 Year-0.42%
5 Year-0.17%

ROCE %

1 Year5.54%
3 Year4.84%
5 Year5.65%

Debt/Equity

0.9365

Price to Cash Flow

1.3

Interest Cover Ratio

1.0026

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 27.10 34.48
Sep 2024 27.10 34.48
Jun 2024 27.10 99.87
Mar 2024 27.10 47.77
Sep 2023 49.62 18.83
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company’s PEG ratio is 0.00717388680596198.
  • The company has an efficient Cash Conversion Cycle of -310.2172 days.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 8.88267219927784.

 Limitations

  • The company has shown a poor profit growth of 6.04493687297503% for the Past 3 years.
  • The company has shown a poor revenue growth of -6.71998177964366% for the Past 3 years.
  • Company has a poor ROE of -0.42389170229646% over the past 3 years.
  • Company has a poor ROCE of 4.8372423646134% over the past 3 years
  • The company is trading at a high PE of 0.
  • Promoter pledging is high as 34.48%.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 57.05 72.38 64.1 67.56 58.75
Total Expenditure 49.34 62.99 59.07 58.5 51.18
Operating Profit 7.71 9.39 5.04 9.06 7.57
Other Income 0.79 0.33 0.47 0.54 1.06
Interest 5.9 6.4 5.25 4.79 4.93
Depreciation 2.45 2.45 2.57 3.64 3.68
Exceptional Items -0.07 -0.2 -0.07 0.03 0
Profit Before Tax 0.07 0.67 -2.38 1.2 0.01
Tax 0.15 0.34 -0.1 0.12 -0.38
Net Profit -0.07 0.33 -2.28 1.08 0.39
Adjusted EPS (Rs.) -0.03 0.14 -0.91 0.43 0.16

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 23.36 23.36 25 25 25
Total Reserves 36.19 36.51 35.35 36.43 36.82
Borrowings 24.49 18.37 19.99 12.9 15.29
Other N/C liabilities 2.95 3.34 2.58 8.32 9.63
Current liabilities 47.7 53.05 56.87 57.99 56.16
Total Liabilities 134.69 134.63 139.78 140.63 142.89
Assets
Net Block 20.78 18.73 32.82 29.42 25.88
Capital WIP 24.8 25.71 13 13.89 14.7
Intangible WIP 0 0 0 0 0
Investments 7.09 7.09 7.09 7.09 7.09
Loans & Advances 22.55 19.95 15.19 11.95 12.44
Other N/C Assets 7.92 5.48 2.9 10.05 18.02
Current Assets 51.55 57.67 68.79 68.24 64.76
Total Assets 134.69 134.63 139.78 140.63 142.89
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.07 0.33 -2.28 1.08 0.39
Adjustment 7.9 8.1 7.1 7.6 7.82
Changes in Assets & Liabilities -17.22 -2.96 0.69 -6.53 -1.26
Tax Paid 0 0 0 0 0
Operating Cash Flow -9.24 5.46 5.51 2.15 6.94
Investing Cash Flow -25.16 -1.2 -3.85 -1.08 -0.93
Financing Cash Flow 35.09 -5.07 -2.65 -1.17 -6.41
Net Cash Flow 0.69 -0.81 -0.99 -0.1 -0.4

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Mar 2024% Jun 2024% Sep 2024% Mar 2025%
promoters 49.62 27.10 27.10 27.10 27.10
kavita suraj zanwar 9.06 1.21 1.21 1.21 1.21
pankaj shriniwas zanwar 16.80 13.76 13.76 13.76 13.76
shakuntala shriniwas zanw... 2.40 2.04 2.04 2.04 2.04
suraj shriniwas zanwar 21.36 10.09 10.09 10.09 10.09
PARTICULARS Sep 2023% Mar 2024% Jun 2024% Sep 2024% Mar 2025%
investors 50.38 72.90 72.90 72.90 72.90
dayal tours and travels i... - 2.00 2.00 2.00 2.00
girija amit sharma 1.82 1.82 2.02 2.23 1.27
prakashchandra rathi 15.90 15.42 - 15.42 9.75
sonali dilip sanklecha - 4.00 4.00 3.79 1.14
vikas kumar ekka - - - - 1.32
vinay kumar tekriwal - - - - 1.15
kaushal sunil tambe - 1.50 1.50 1.10 -
ravi ashok kothari - 2.52 2.52 1.32 -
sahi trading private limi... 4.38 4.02 4.02 1.22 -
amitkumar ramanlal lodha - - 1.04 - -
archana mandhani 1.16 1.16 1.16 - -
prakashchandra rathi . - - 15.42 - -
samar shahaji ransing - - 1.05 - -
shweta sachin bhansali - 1.05 1.05 - -
koushal govindprasad shar... 1.60 1.60 - - -

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2020
Annual Report 2019

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Cian Healthcare informs about update on CoC 7 Dec, 12:44 PM Cian Healthcare informs about outcome of AGM 8 Oct, 4:36 PM Cian Healthcare informs about CoC meeting proceedings 12 Sep, 4:33 PM Cian Healthcare informs about change in corporate office address 23 Aug, 5:03 PM Cian Healthcare informs about published announcement 19 Aug, 5:15 PM Cian Healthcare informs about disclosure 21 Jun, 3:02 PM Cian Healthcare informs about receipt of adjudication order of penalties 19 Mar, 4:55 PM Cian Healthcare informs about disclosure 6 Dec, 5:06 PM Cian Healthcare enters into agreement with HLL Lifecare 6 Dec, 12:48 PM Cian Healthcare informs about disclosure 9 Nov, 2:23 PM Cian Healthcare informs about disclosure 4 Nov, 12:16 PM Cian Healthcare informs about disclosure 12 Oct, 3:12 PM Cian Healthcare informs about appointment of additional director 12 Oct, 3:04 PM Cian Healthcare inks merchant export agreement with Tamil Pharma 11 Oct, 5:13 PM Cian Healthcare informs about disclosure 11 Oct, 4:42 PM Cian Healthcare enters into agreement with CHI Pharmaceuticals, Nigeria 22 Aug, 12:59 PM Cian Healthcare gets nod to dispose off 100% stake in Dr. Smiths Biotech 10 Jun, 4:27 PM Cian Healthcare submits revised audited financial results 2 Jun, 4:01 PM Cian Healthcare informs about board meeting 24 May, 12:38 PM Cian Healthcare informs about outcome of board meeting 27 Sep, 3:18 PM Cian Healthcare informs about annual report 5 Sep, 5:08 PM Cian Healthcare informs about appointment of director 26 Aug, 12:57 PM Cian Healthcare informs about compliance certificate 22 Apr, 1:19 PM Cian Healthcare informs about compliance certificate 22 Apr, 1:01 PM Cian Healthcare informs about disclosure 27 Dec, 1:03 PM Cian Healthcare informs about board meeting 18 Dec, 11:34 AM Cian Healthcare informs about EGM proceedings 25 Nov, 4:47 PM Cian Healthcare informs about outcome of EGM meeting 24 Nov, 1:40 PM Cian Healthcare informs about newspaper publication 23 Nov, 1:41 PM Cian Healthcare informs outcome of about board meeting 22 Nov, 10:43 AM Cian Healthcare informs about EGM 1 Nov, 11:07 AM Cian Healthcare informs about revised notice of EGM 23 Oct, 10:21 AM Cian Healthcare informs about resignation of director 16 Oct, 3:22 PM Cian Healthcare informs about outcome of EGM 12 Oct, 12:52 PM Cian Healthcare informs about certificate 6 Oct, 9:55 AM Cian Healthcare informs about AGM 30 Sep, 4:50 PM Cian Healthcare informs about EGM notice 20 Sep, 11:32 AM Cian Healthcare informs about outcome of board meeting 18 Sep, 1:09 PM

Cian Healthcare Stock Price Analysis and Quick Research Report. Is Cian Healthcare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Cian Healthcare. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Cian Healthcare has a PE ratio of -0.457776477918643 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Cian Healthcare has ROA of 0.2748% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Cian Healthcare has a Current ratio of 1.1532.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Cian Healthcare has a ROE of 0.8188%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Cian Healthcare has a Debt to Equity ratio of 0.9365 which means that the company has low proportion of debt in its capital.

  • Sales growth: Cian Healthcare has reported revenue growth of -13.0436% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Cian Healthcare for the current financial year is 12.8778581386205%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Cian Healthcare is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Cian Healthcare is Rs -7.8641. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Cian Healthcare in Ticker for free. Also, one can get the intrinsic value of Cian Healthcare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Cian Healthcare FAQs

Q1. What is Cian Healthcare share price today?
Ans: The current share price of Cian Healthcare is Rs 3.6.

Q2. What is the market capitalisation of Cian Healthcare?
Ans: Cian Healthcare has a market capitalisation of Rs 8.99847504 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Cian Healthcare?
Ans: The PE ratio of Cian Healthcare is -0.457776477918643 and the P/B ratio of Cian Healthcare is 0.213462359470613, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Cian Healthcare share?
Ans: The 52-week high share price of Cian Healthcare is Rs 6.61, and the 52-week low share price of Cian Healthcare is Rs 2.97.

Q5. Does Cian Healthcare pay dividends?
Ans: Currently, Cian Healthcare does not pay dividends. Dividend yield of Cian Healthcare is around 0%.

Q6. What are the face value and book value of Cian Healthcare shares?
Ans: The face value of Cian Healthcare shares is Rs 10, while the book value per share of Cian Healthcare is around Rs 16.8648. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Cian Healthcare?
Ans: Cian Healthcare has a total debt of Rs 41.0089 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Cian Healthcare?
Ans: The ROE of Cian Healthcare is 0.8188% and ROCE of Cian Healthcare is 5.5351%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Cian Healthcare a good buy for the long term?
Ans: The Cian Healthcare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Cian Healthcare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Cian Healthcare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Cian Healthcare’s financials?
Ans: You can review Cian Healthcare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Cian Healthcare
X